|Articles|April 1, 2018
- Applied Clinical Trials-04-01-2018
- Volume 27
- Issue 4
Applied Clinical Trials, April 2018 Issue (PDF)
Click the title above to open the Applied Clinical Trials April 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Barriers and Solutions to Smart Clinical Program Designsover 8 years ago
MythBusting: 6 eConsent Myths we Need to Correct in 2018over 8 years ago
Eli Lilly Joins the Force on Clinical Trial Patient Educationover 8 years ago
The Pull and Tug on Orphan Drug Developmentover 8 years ago
The Commedia Dell'Arte of the EMA Relocationover 8 years ago
Patient Input into Leveraging the Healthcare Professional’s Roleover 8 years ago
The Impetus for Natural History Studies in Rare Disease R&Dover 8 years ago
All in Our Heads? The Power of Placebo ResponseAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
3
Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5